companydata.dkcompanydata.dk

ZEMA Pharma Consulting ApS: Financial statements 2024

CVR: 42680427

Source: annual report 2024, Danish Business Authority

01/10/2023 – 30/09/2024

ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 130,753 and a net result of DKK -281,625 compared with DKK 812,354 the year before. That is a decrease of 91.1% compared with the year before. Equity in the 2024 report amounted to DKK 571,287. The solvency ratio was 90.3%. The company had 1 employee in the financial year.

Gross Profit
DKK 130,753
Profit/Loss
DKK -281,625
Equity
DKK 571,287
Total Assets
DKK 632,672
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-131K-282K571K1
2023-1.5M812K853K1
2022-1.1M790K830K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

About ZEMA Pharma Consulting ApS

ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. Equity in the 2025 report amounted to DKK 354,543.

Source: annual report 2025, Danish Business Authority

Other financial years